title: [Irradiation in stereotactic conditions: prerequisites].
abstract: Indications of treatment by stereotactic body radiotherapy are dramatically increasing due to new potential indications. The conditions associated with the treatment delivery are multiple. The first step of the process is crucial. It is related to the validation of the indication proposed during the multidisciplinary meeting as regard the evidence-based proof of the concept. These emerging techniques mainly extracranial stereotactic body irradiation do not benefit from long-term evaluation in terms of efficiency as well as normal tissue late toxicities. Priority should be given to prospective independent clinical trials, validated by an independent scientific committee, performed under a relevant and well dedicated multicentric quality assurance program aiming to improve knowledge and selection of indications. The SFRO is still working with others professionals on the definition of the conditions for the implementation of such treatments and actively collaborates with the authorities to define the appropriate conditions to preserve the quality of the treatment delivery under these specific conditions.
authors.affiliation: Département de radiothérapie, centre Georges-François-Leclerc, 1, rue Professeur-Marion, 21034 Dijon cedex, France. Electronic address: pmaingon@cgfl.fr.
authors.forename: P
authors.initials: P
authors.lastname: Maingon
authors.affiliation: Service de physique médicale, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors.forename: A
authors.initials: A
authors.lastname: Lisbona
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards; D005602:France; D006801:Humans; D033183:Interdisciplinary Communication; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000601:surgery*; D058958:Organs at Risk; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D011832:Radiation Injuries / Q000517:prevention & control; D018787:Radiation Oncology / Q000458:organization & administration; D016634:Radiosurgery / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D011880:Radiotherapy Planning, Computer-Assisted; D012955:Societies, Medical
keywords: Intracranial stereotaxic radiotherapy; Maladie oligométastastatique; Metastases; Métastases; Oligometastatic disease; Radiotherapy; Radiothérapie; Regulatory affairs; Réglementation; Stereotactic body radiotherapy; Stéréotaxie extracrânienne; Stéréotaxie intracrânienne